Making diagnostic imaging possible for patients with cardiac implants

by Shantell Kirkendoll
Making diagnostic imaging possible for patients with cardiac implants
Dr. Eric D. Good, left, implants ICD at University of Michigan Cardiovascular Center.

The University of Michigan Frankel Cardiovascular Center is on the forefront of making diagnostic imaging possible for patients with cardiac implants.

Electrophysiologist Eric D. Good, D.O., has implanted the state's first patient with BIOTRONIK's Iforia heart device. It's the only implantable cardioverter-defibrillator (ICD) approved for investigational use in (MRI).

The device is commercially available, but is in the newest phase of the ongoing ProMRI trial, a study that will examine ProMRI technology in the MRI environment.

"This technology is intended to allow full diagnostic capabilities for our who are likely to benefit from MRI scans," says Good.  "We are very excited to be participating in the ProMRI trial."

Every year, more than 300,000 people are implanted with ICD systems to regulate their heartbeat, and studies estimate that 50 percent to 75 percent will need an MRI scan in their lifetime.

MRI scans often provide diagnostic capabilities for certain diseases or conditions that cannot be adequately examined by x-ray, computerized tomography (CT) or ultrasound.

The strong magnetic forces applied during MRIs can potentially have a negative effect on both the device and leads, and are usually not recommended for pacemaker and ICD patients.

"MRI is a safe and reliable diagnostic technology, and demand for imaging studies is growing," says Theofanie Mela, M.D., director of Pacer and ICD Clinic at Massachusetts General Hospital in Boston. "ICD patients are frequently recommended for MRI scans, but until now they have been unable to receive them."

The ICD ProMRI with exclusion zone study is designed to confirm the safety and efficacy of BIOTRONIK's Iforia ICD during an MRI scan. All the devices in the study are conditionally approved by the U.S. Food and Drug Administration for use in the study, but still await FDA approval for use in the MRI environment.

Aside from featuring ProMRItechnology, the single chamber Iforia series is one of the smallest ICDs in the world and also offers more than 11 years longevity. This allows for a low replacement rate—a benefit for both patients and the health care system.

The latest phase of the ProMRI clinical study will recruit and evaluate 172 patients at 35 U.S. investigational centers, including the University of Michigan Cardiovascular Center.

The U-M's Heart Rhythm Program focuses on the diagnosis and treatment of all types of arrhythmias, or abnormal heart rhythms, including atrial fibrillation and flutter, sick sinus syndrome, sinus tachycardia, sinus bradycardia, ventricular tachycardia and genetic arrhythmia syndromes such as prolonged QT syndrome.

add to favorites email to friend print save as pdf

Related Stories

Magnetic resonance imaging with side effects

Apr 30, 2012

Great care should be taken when performing magnetic resonance imaging (MRI) in patients with a cardiac pacemaker. Henning Bovenschulte and his co-authors review recent findings in the latest issue of Deutsches Ärzteblatt In ...

New implanted defibrillator works well without touching heart

Aug 26, 2013

A new type of defibrillator implanted under the skin can detect dangerously abnormal heart rhythms and deliver shocks to restore a normal heartbeat without wires touching the heart, according to research in the American Heart ...

Recommended for you

Real-time volume imaging of hearts

17 hours ago

A new ultrasound system from Siemens enables doctors to carry out heart examinations through the esophagus for the first time. The system supplies 3D images of the heart as well as additional real-time information ...

Post-PCI bleeding rates vary widely across hospitals

Nov 27, 2014

(HealthDay)—Patient case-mix and procedural factors may contribute to wide variation in the hospital rates of bleeding after percutaneous coronary intervention (PCI), according to research published online ...

Most seniors eligible for statin Rx under new guidelines

Nov 25, 2014

(HealthDay)—Most older Americans qualify for treatment with statins under new guidelines for the treatment of blood cholesterol released late last year by the American College of Cardiology and the American ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.